Key result
Genetic predisposition to AF linked to ~14% higher dementia risk.
Why the study?
It remained unclear whether the observed correlation between AF and dementia reflects causation or shared risk factors.
Does genetic predisposition to atrial fibrillation increase the risk of overall dementia and its subtypes?
Does genetic predisposition to atrial fibrillation increase the risk of overall dementia and its subtypes?
Odds Ratio: 1.14 (95% CI 1.023–1.271)
p-value: p=0.018
This study provides novel genetic evidence supporting a causal effect of atrial fibrillation on overall and vascular dementia, which appears to be potentially mediated by ischemic stroke and low cardiac output.
Supports modest causal AF-dementia link via stroke; leaves open whether rhythm or anticoagulation strategies alter risk.
Background The knowledge gap regarding whether the correlation between atrial fibrillation (AF) and dementia in observational studies is causation or driven by other shared risk factors remains substantially unfilled. Methods and Results We performed a comprehensive 2‐sample Mendelian randomization study to evaluate the causal effect of AF on overall dementia and its subtypes, including vascular dementia, Alzheimer dementia, Lewy body dementia, and frontotemporal dementia. The primary results in inverse variance–weighted analyses were further validated by various Mendelian randomization sensitivity analyses. Additionally, we conducted multivariable Mendelian randomization to examine 10 candidate mediators of the causal association of AF and dementia. Genetic predisposition to AF was modestly associated with an increased risk of overall dementia (odds ratio, 1.140 [95% CI, 1.023–1.271]; P =0.018) and strongly associated with vascular dementia (odds ratio, 1.350 [95% CI, 1.076–1.695]; P =0.010). Genetically predicted AF indicated neutral effects on Alzheimer dementia, Lewy body dementia, and frontotemporal dementia. In multivariable Mendelian randomization analysis, the total effect of AF on overall dementia was remarkably attenuated by adjusting for genetic effect for ischemic stroke (odds ratio, 1.068 [95% CI, 0.953–1.197]; P =0.259) and low cardiac output (odds ratio, 1.046 [95% CI, 0.926–1.181]; P =0.475), indicating that the causal association of genetically predicted AF with dementia was potentially mediated by ischemic stroke and low cardiac output. The causal effect of genetically predicted AF on dementia was independent of cerebral small‐vessel disease and brain volume phenotypes. Conclusions Our findings provided novel evidence supporting the causal effect of genetically predicted AF on dementia mediated by ischemic stroke and low cardiac output. Future clinical trials are warranted to evaluate the potential role of appropriate AF management in dementia prevention.
No takes yet. Share an insight, caveat, or question.
Li et al. (2023) studied Atrial fibrillation and dementia. Genetic predisposition to atrial fibrillation vs. Absence of genetic predisposition to atrial fibrillation was evaluated on Overall dementia (OR 1.140, 95% CI 1.023-1.271, p=0.018). Genetic predisposition to atrial fibrillation was modestly associated with an increased risk of overall dementia (OR 1.140, 95% CI 1.023-1.271, p=0.018).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: